Arcus Biosciences, Inc. (RCUS) Free cash flow 2016–2025
Arcus Biosciences, Inc. (RCUS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$484.0MFY2025 · since FY2016: -$17.0M → -$484.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$484.0M | -175.0% |
| FY2024 | -$176.0M | +46.7% |
| FY2023 | -$330.0M | -176.4% |
| FY2022 | $432.0M | +253.2% |
| FY2021 | -$282.0M | -361.1% |
| FY2020 | $108.0M | +243.3% |
| FY2019 | -$75.4M | -61.3% |
| FY2018 | -$46.7M | -52.9% |
| FY2017 | -$30.6M | -79.4% |
| FY2016 | -$17.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice